Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 1;41(2):129-138.
doi: 10.3343/alm.2021.41.2.129.

Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19

Affiliations
Review

Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19

Sarita Choudhary et al. Ann Lab Med. .

Abstract

Since its first report in December 2019, coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly emerged as a pandemic affecting nearly all countries worldwide. As the COVID-19 pandemic progresses, the need to identify genetic risk factors for susceptibility to this serious illness has emerged. Host genetic factors, along with other risk factors may help determine susceptibility to respiratory tract infections. It is hypothesized that the ACE2 gene, encoding angiotensin-converting enzyme 2 (ACE2), is a genetic risk factor for SARS-CoV-2 infection and is required by the virus to enter cells. Together with ACE2, transmembrane protease serine 2 (TMPRSS2) and dipeptidyl peptidase-4 (DPP4) also play an important role in disease severity. Evaluating the role of genetic variants in determining the direction of respiratory infections will help identify potential drug target candidates for further study in COVID-19 patients. We have summarized the latest reports demonstrating that ACE2 variants, their expression, and epigenetic factors may influence an individual's susceptibility to SARS-CoV-2 infection and disease outcome.

Keywords: Angiotensin-converting enzyme 2 (ACE2) variants; COVID-19; Epigenetics; SARS-CoV-2 infection; Serine 2 (TMPRSS2); Transmembrane protease.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

None declared.

Similar articles

Cited by

References

    1. Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, Kim SY, et al. Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020;40:351–60. doi: 10.3343/alm.2020.40.5.351. - DOI - PMC - PubMed
    1. Mitra P, Misra S, Sharma P. COVID-19 pandemic in India: what lies ahead. Ind J Clin Biochem. 2020;35:257–9. doi: 10.1007/s12291-020-00886-6. - DOI - PMC - PubMed
    1. Sung H, Roh KH, Hong KH, Seong MW, Ryoo N, Kim HS, et al. COVID-19 molecular testing in Korea: practical essentials and answers from experts based on experiences of emergency use authorization assays. Ann Lab Med. 2020;40:439–47. doi: 10.3343/alm.2020.40.6.439. - DOI - PMC - PubMed
    1. Mitra P, Suri S, Goyal T, Misra R, Singh K, Garg MK, et al. Association of comorbidities with coronavirus disease 2019: a review. Ann Natl Acad Med Sci (India) 2020;56:102–11. doi: 10.1055/s-0040-1714159. - DOI
    1. WHO. [Updated on Jul 2020];Coronavirus disease (COVID-19) dashboard. https://covid19.who.int.

MeSH terms